Literature DB >> 11263988

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors.

N Okada1, Y Tsukada, S Nakagawa, H Mizuguchi, K Mori, T Saito, T Fujita, A Yamamoto, T Hayakawa, T Mayumi.   

Abstract

Recent studies have demonstrated the usefulness of dendritic cells (DCs) genetically modified by adenovirus vectors (Ad) to immunotherapy, while sufficient gene transduction into DCs is required for high doses of Ad. The RT-PCR analysis revealed that the relative resistance of DCs to Ad-mediated gene transfer is due to the absence of Coxsackie-adenovirus receptor expression, and that DCs expressed adequate alpha(v)-integrins. Therefore, we investigated whether fiber-mutant Ad containing the Arg-Gly-Asp (RGD) sequence in the fiber knob can efficiently transduce and express high levels of the LacZ gene into DCs. The gene delivery by fiber-mutant Ad was more efficient than that by conventional Ad in both murine DC lines and normal human DCs (NHDC). Furthermore, NHDC transduced with fiber-mutant Ad and conventional Ad at 8000-vector particles/cell resulted in a 70-fold difference in beta-galactosidase activity. We propose that alpha(v)-integrin-targeted Ad is a very powerful tool with which to implement DC-based vaccination strategies. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263988     DOI: 10.1006/bbrc.2001.4527

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Recombinant adenovirus type 5 vectors that target DC-SIGN, ChemR23 and alpha(v)beta3 integrin efficiently transduce human dendritic cells and enhance presentation of vectored antigens.

Authors:  Casey A Maguire; Ramil Sapinoro; Natasha Girgis; Sol M Rodriguez-Colon; Servio H Ramirez; Jennifer Williams; Stephen Dewhurst
Journal:  Vaccine       Date:  2005-08-24       Impact factor: 3.641

2.  Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia.

Authors:  Mariko Okamoto; Ai Asamura; Ko Tanaka; Takefumi Soeda; Kyo Watanabe; Hiroyuki Mizuguchi; Teruo Ikeda
Journal:  Vet Res Commun       Date:  2016-10-16       Impact factor: 2.459

3.  Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.

Authors:  Nicola J Philpott; Marcelo Nociari; Keith B Elkon; Erik Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

4.  Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.

Authors:  Gisselle N Medina; Nestor Montiel; Fayna Diaz-San Segundo; Diego Sturza; Elizabeth Ramirez-Medina; Marvin J Grubman; Teresa de los Santos
Journal:  Clin Vaccine Immunol       Date:  2015-11-25

5.  Adenoviral vector-based strategies for cancer therapy.

Authors:  Anurag Sharma; Manish Tandon; Dinesh S Bangari; Suresh K Mittal
Journal:  Curr Drug ther       Date:  2009-05-01

6.  Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.

Authors:  Juliette K Tinker; Jie Yan; Reece J Knippel; Panos Panayiotou; Kenneth A Cornell
Journal:  Toxins (Basel)       Date:  2014-04-22       Impact factor: 4.546

7.  Tumor necrosis factor alpha-gene therapy for an established murine melanoma using RGD (Arg-Gly-Asp) fiber-mutant adenovirus vectors.

Authors:  Yuka Okada; Naoki Okada; Shinsaku Nakagawa; Hiroyuki Mizuguchi; Koichi Takahashi; Nobuyasu Mizuno; Takuya Fujita; Akira Yamamoto; Takao Hayakawa; Tadanori Mayumi
Journal:  Jpn J Cancer Res       Date:  2002-04

Review 8.  Immune cell recruitment and cell-based system for cancer therapy.

Authors:  Jian-Qing Gao; Naoki Okada; Tadanori Mayumi; Shinsaku Nakagawa
Journal:  Pharm Res       Date:  2007-09-22       Impact factor: 4.200

9.  In vivo gene delivery and expression by bacteriophage lambda vectors.

Authors:  H A Lankes; C N Zanghi; K Santos; C Capella; C M P Duke; S Dewhurst
Journal:  J Appl Microbiol       Date:  2007-05       Impact factor: 3.772

Review 10.  Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.

Authors:  Tatiana I Samoylova; Timothy D Braden; Jennifer A Spencer; Frank F Bartol
Journal:  Curr Med Chem       Date:  2017-11-20       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.